79 hasil untuk "Benjamin Besse"
Menampilkan 1–20 · 0,57 detik · RSS
-
Artikel Jurnal
Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment
Brain metastases (BM) are common in non-small cell lung cancer patients including in molecularly selected populations, such as EGFR-mutant and ALK-rearranged tumors. They are associated with a reduced quality of life, and are commonly the first site of progression for patients receiving tyrosine…
-
Artikel Jurnal
Second-line combination therapies in nonsmall cell lung cancer without known driver mutations
In advanced nonsmall cell lung cancer (NSCLC) patients, platinum-based combination chemotherapy is standard treatment in the first-line setting; however, the large majority of patients ultimately progress. For more than a decade, single-agent therapy with docetaxel, pemetrexed or erlotinib has been…
-
Artikel Jurnal
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
In the genomics era, our main goal should be to identify large and meaningful differences in small, molecularly selected groups of patients. Classical phase I, II and III models for drug development require large resources, limiting the number of experimental agents that can be tested and making…
-
Artikel Jurnal
The efficacy of immune checkpoint inhibitors in thoracic malignancies
The advent of immune checkpoint inhibitors (ICIs) has rapidly transformed the treatment paradigm for multiple cancer types, including thoracic malignancies. In advanced non-small cell lung cancer (NSCLC), ICIs have shifted treatment paradigm and improved overall survival reaching almost one-third…
-
Artikel Jurnal
Multiple colic intussusceptions
Abstract Adult large bowel intussusception represents a small minority of intestinal intussusceptions. Main causes involve primary or secondary bowel malignancies. Although multiple small intestine intussusceptions have already been reported, simultaneous large bowel intussusceptions have not been…
-
Artikel Jurnal
KRAS oncogene in lung cancer: focus on molecularly driven clinical trials
KRAS mutations are the most frequent molecular abnormalities found in one out of four nonsmall cell lung cancers (NSCLC). Their incidence increases in cases of adenocarcinoma, smokers and Caucasian patients. Their negative value in terms of prognosis and responsiveness to both standard chemotherapy…
-
Artikel Jurnal
A microsimulation model to assess the economic impact of immunotherapy in non-small cell lung cancer
Introduction Immunotherapy has become the standard of care in advanced non-small cell lung cancer (NSCLC). We aimed to quantify the economic impact, in France, of anti-PD-1 therapy for NSCLC. Methods We used patient-level data from the national ESCAP-2011-CPHG cohort study to estimate time to…
-
Artikel Jurnal
HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker
Since the advent of anti-PD1 immune checkpoint inhibitor (ICI) immunotherapy, cutaneous melanoma has undergone a true revolution with prolonged survival, as available 5-year updates for progression-free survival and overall survival demonstrate a durable clinical benefit for melanoma patients…
-
Artikel Jurnal Teks lengkap
Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer
Over the past years, targeted therapies using tyrosine kinase inhibitors (TKI) have led to an increase in progression-free survival and response rate for a subgroup of non-small cell lung cancer (NSCLC) patients harbouring specific gene abnormalities compared with chemotherapy. However long-lasting…
Juga tersedia di: DOAJ
-
Artikel Jurnal Teks lengkap
Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer
Objective: To study the prognostic value of baseline leukocytosis or neutrophiliain two retrospective cohorts of stage III Non-Small Cell Lung Cancer (NSCLC) patients. Materials and methods: Clinical records of consecutive previously untreated NSCLC patients in our Institution between June 2001 and…
Juga tersedia di: DOAJ
-
Artikel Jurnal
IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment
Background As the immune system is compromised in patients with cancer, therapeutic strategies to stimulate immunity appear promising, to avoid relapse and increase long-term overall survival. Interleukin-15 (IL-15) has similar properties to IL-2, but does not cause activation-induced cell death…
-
Artikel Jurnal
Bilateral myelin oligodendrocyte glycoprotein antibody-associated disease after cataract surgery
Purpose: To report an unusual presentation of bilateral myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) associated with optic neuritis occurring during the early post-operative cataract surgical period. Methods: This was an observational case report. Results: A 67-year-old…
-
Artikel Jurnal
Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications
Tumor derived biomarkers including circulating tumor DNA (ctDNA) and/or circulating tumors cells (CTCs) may be detected and quantified through liquid biopsy (LB). ctDNA analysis through LB is a validated tool for monitoring response to systemic treatment and detecting molecular mechanisms of…
-
Artikel Jurnal Teks lengkap
Prognostic value of histogram analysis in advanced non-small cell lung cancer: a radiomic study
INTRODUCTION: Quantitative assessment of heterogeneity by histogram analysis (HA) of tumor images can potentially provide a non-invasive prognostic biomarker. We assessed the prognostic value of HA and evaluated a correlation with molecular signature. RESULTS: CT scans performed between July 2009…
-
Artikel Jurnal
Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer
We previously reported that elevated levels of diazepam binding inhibitor (DBI), also called ‘endozepine’ because it acts as an endogenous benzodiazepine equivalent on the gamma-aminobutyric acid type A receptor, constitutes a potential risk factor for the diagnosis of non-small cell lung cancer…
-
Artikel Jurnal Teks lengkap
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
-
Artikel Jurnal Teks lengkap
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆